This mentioned medicine contains Fluvoxamine Maleate as the main active component. This active agent shows antidepressant, anti-obsessive-compulsive, and antibulimic activities. It blocks serotonin reuptake by inhibiting the serotonin reuptake pump of the presynaptic neuronal membrane. It results in an increase in serotonin levels within the synaptic cleft. It reduced serotonin turnover leading to antidepressant and ant obsessive-compulsive effects.
This medication is intended to treat obsessive-compulsive disorder (OCD). Luvox helps reduce persistent/unwanted thoughts called obsessions and urges to perform repeated tasks called compulsions like hand-washing, counting, and checking. These obsessions and compulsions interfere with daily activities. The medication is called a selective serotonin reuptake inhibitor. It helps to restore the balance of a certain natural substance in the brain.
Given the selective serotonin reuptake inhibitor drug, Luvox affects neurotransmitters. These are chemicals, which are used by nerves in the brain to communicate with each other. They travel across the spaces between nerves and then attach to receptors on other nerves. It is believed that an imbalance in neurotransmitters causes depression and other psychiatric disorders. The medication inhibits the uptake of serotonin, a neurotransmitter, from the spaces between nerve cells following its release. As a consequence, there is more serotonin available in the spaces to attach to other nerves and stimulate them.
Some drugs should not be used with fluvoxamine
This medication is available in dosages as mentioned below:
- 50 mg: This tablet should be taken with or without food as advised by the doctor, usually once or twice a day at bedtime
- 100 mg: It should be taken once a day before or after a meal, as mentioned in the prescription by the doctor
Children might be more sensitive to the side effects of this medication, especially loss of appetite and weight loss. Monitor the weight and height of children who are consuming this medicine.